KaydedilenlerDerginizi ekleyin

Dergiler / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 1

The association between MRI texture analysis and chemoradiotherapy outcomes in glioblastoma cases

Neslihan KURTUL
Murat BAYKARA
Sayfa
17–21
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Young age, high performance statusand low entropy value after radiotherapywere associated with longer survival according to the Kaplan-Meier analysis (p = 0.014, p = 0.031, p = 0.034, respectively).Conclusion: Based on these results,entropy measurements can be recommended for use as a new prognostic factor for glioblastoma.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Texture analysis can provide additional information regarding tumor heterogeneity and treatment response.
📊
Temel Bulgular & Veri:The aim of this study was to evaluate whether MRI texture analysis can predict radiotherapy response and survival in glioblastoma patients.Material and Methods: A total of 26 patients with pathologically confirmed glioblastoma who had received curative chemoradiotherapy (60 Gy radiotherapy + temozolomide) underwent contrast-enhanced cranial MRI texture analysis before and after chemoradiotherapy.
💡
Sonuç & Katkı:Young age, high performance statusand low entropy value after radiotherapywere associated with longer survival according to the Kaplan-Meier analysis (p = 0.014, p = 0.031, p = 0.034, respectively).Conclusion: Based on these results,entropy measurements can be recommended for use as a new prognostic factor for glioblastoma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: Texture analysis can provide additional information regarding tumor heterogeneity and treatment response. The aim of this study was to evaluate whether MRI texture analysis can predict radiotherapy response and survival in glioblastoma patients.Material and Methods: A total of 26 patients with pathologically confirmed glioblastoma who had received curative chemoradiotherapy (60 Gy radiotherapy + temozolomide) underwent contrast-enhanced cranial MRI texture analysis before and after chemoradiotherapy. The region of interest was determined as the active tumor area in post-contrast axial T1 sections. The gray level intensity, standard deviation of histogram, entropy, uniformity, skewness, and kurtosis values were determined by texture analysis.Results: Comparison of the pre- and post-radiotherapy values showed an increase in entropy (6.97±0.37 vs. 7.20±0.30, p = 0.014) and a decrease in uniformity (0.21±0.12 vs.0.16±0.08, p = 0.049). Therefore, radiation therapy was determined to have caused increased heterogeneity in the active tumor region of glioblastoma. The median follow-up was 7.5 [95% confidence interval (1.8-21.63)] months, while the median overall survival was 12.5 [95% confidence interval (4.24-20.81)] months. Young age, high performance statusand low entropy value after radiotherapywere associated with longer survival according to the Kaplan-Meier analysis (p = 0.014, p = 0.031, p = 0.034, respectively).Conclusion: Based on these results,entropy measurements can be recommended for use as a new prognostic factor for glioblastoma.

🔖

Bu Makaleye Atıf Yap

KURTUL, N., BAYKARA, M. (2022). The association between MRI texture analysis and chemoradiotherapy outcomes in glioblastoma cases. Annals of Medical Research, Cilt: 26 - Sayı: 1, 17–21. https://ajindex.com/articles/447255

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Johnson, DR, O’Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neuro Oncol 2012;107:359-64
  2. Mazurowski MA, Desjardins A, Malof JM, Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro Oncol 2013;15:1389-94
  3. Stupp R, Mason, MP Van Den Bent MJ, et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96
  4. Brady, L.W., C.A. Perez, and D.E. Wazer, Perez & Brady’s principles and practice of radiation oncology. 2013: Lippincott Williams & Wilkins
  5. Provenzale JM, Ison C, Delong D. Bidimensional measurements in brain tumors: assessment of interobserver variability. AJR Am J Roentgenol 2009;193:515-22
  6. Castellano G, Bonilha L, Li, LM, Texture analysis of medical images. Clin Radiology 2004;59:1061-9
  7. Just N, Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 2014;111:2205-13
  8. Yu H, Caldwell C, Mah K, et al., Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys 2009;75:618-25
  9. Yip C, Davnall F, Kozarski R, et al., Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus 2015;28:172-9
  10. Mattonen SA, Palma DA, Haasbeek CJ, et al. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 2014;41:033502
  11. Hocquelet A, Auriac T, Perier C, et al. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy. Eur Radiol 2018;28:2801-11
  12. Jalil O, Afaq A, Ganeshan B, et al., Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Dis 2017;19:349-62
  13. Zacharaki EI, Wang S, Chawla S, et al. Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. Magn Reson Med 2009;62:1609-18
  14. Pallavi T, Prateek P, Lisa R, et al., Texture Descriptors to distinguish Radiation Necrosis from Recurrent Brain Tumors on multi-parametric MRI. Proc SPIE Int Soc Opt Eng 2014;9035:90352B
  15. Wen PY, Macdonald DR, Reardon DA, et al., Updated response assessment criteria for high-grade gl